{
  "docId": "019de076-9bf1-74fc-a35c-18d7d86ef549",
  "docSlug": "50ca0b93fcc5c9425705539b9e6fcccb",
  "documentTitle": "Erasca | Investor Presentation Deck | 41 slides",
  "authorId": "erasca",
  "authorName": "Erasca",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 5,
  "pageCount": 41,
  "prevPage": 4,
  "nextPage": 6,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "balanced",
  "nDataPoints": 7,
  "notes": "The slide uses a Gantt-style chart to represent clinical trial progress.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-9bf1-74fc-a35c-18d7d86ef549/5",
  "deckHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549",
  "deckJsonHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549.json",
  "deckAnchorHref": "/decks/019de076-9bf1-74fc-a35c-18d7d86ef549#slide-5",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.25,
        "x": 0.495,
        "y": 0.245
      },
      "kind": "chart",
      "text": "Clinical development progress bars for 7 programs",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7d0f8fb7-a04e-425a-aaba-f6e056f2474c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.41,
        "x": 0.028,
        "y": 0.89
      },
      "kind": "legend",
      "text": "small molecule, large molecule, TCR T cell therapy, ERASCA investment",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6b51198b-2642-425d-8aed-6ed2b1490bff",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.88,
        "x": 0.06,
        "y": 0.245
      },
      "kind": "table",
      "text": "Pipeline table with columns: Program/Company, Target, Modality, Indication, Discovery, IND-enabling, Phase 1, Phase 2, Phase 3, Worldwide Rights",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49dfa8b2-611a-415c-88c3-558c854d7ea9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.63,
        "x": 0.028,
        "y": 0.045
      },
      "kind": "title",
      "text": "Deep modality-agnostic RAS/MAPK pathway-focused pipeline",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3aebeabc-92b8-4786-b97b-fe4b94baa7db",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "gantt-chart",
      "slug": null,
      "matchId": "d5d43761-9a3f-443f-87f8-c1280a9c4351",
      "evidence": "The pipeline table uses horizontal bars to represent the duration and stage of clinical trials.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 5,
      "from": 1,
      "beatId": "7c14303c-7cf7-4655-a29d-3b1346ff20bb",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Setup",
      "beatSlug": "setup",
      "evidence": "Introduction to Erasca's vision and pipeline",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "75b8c386-e12c-4807-b0f3-5e69211b24c3",
      "evidence": "The deck highlights the unmet needs and limitations of current treatments",
      "position": 0,
      "objective": "What is the cost of not investing in Erasca's pipeline?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}